calendar
18,993 catalysts · 18,987 approval · 5,159 phase readout · 5,000 device 510k · 4,728 grant · 2,516 8k filing · 2,000 device pma
18,993 catalysts · 18,987 approval · 5,159 phase readout · 5,000 device 510k · 4,728 grant · 2,516 8k filing · 2,000 device pma
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
Sponsor: ACTELION. Form: TABLET. Route: ORAL
Sponsor: LUPIN. Form: CAPSULE. Route: ORAL
Sponsor: ACERTIS PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: HARROW EYE. Form: SOLUTION/DROPS. Route: OPHTHALMIC
Sponsor: XTTRIUM. Form: SOLUTION. Route: TOPICAL
Sponsor: BAUSCH. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: CEPHALON. Form: TROCHE/LOZENGE. Route: TRANSMUCOSAL
Sponsor: BAXTER HLTHCARE CORP. Form: INJECTABLE, LIPOSOMAL. Route: INJECTION
Sponsor: ORGANON USA LLC. Form: INJECTABLE. Route: SUBCUTANEOUS
Sponsor: IMPAX. Form: INJECTABLE. Route: INTRAMUSCULAR, SUBCUTANEOUS
Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION
Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL
Sponsor: INNOGENIX. Form: TABLET. Route: ORAL
Sponsor: SANDOZ. Form: CAPSULE. Route: ORAL
Sponsor: ORGANON. Form: TABLET. Route: ORAL
Sponsor: ORGANON. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
Sponsor: ACERTIS PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: HARROW EYE. Form: SOLUTION/DROPS. Route: OPHTHALMIC
Sponsor: EPIC PHARMA LLC. Form: TABLET. Route: ORAL
Sponsor: PFIZER. Form: INJECTABLE. Route: SUBCUTANEOUS
Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL
Sponsor: PF PRISM CV. Form: POWDER. Route: INTRAVENOUS
Sponsor: PF PRISM CV. Form: FOR SUSPENSION. Route: ORAL
Sponsor: DANCO LABS LLC. Form: TABLET. Route: ORAL
Sponsor: PHARMOBEDIENT. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
Sponsor: MYLAN TECHNOLOGIES. Form: FILM, EXTENDED RELEASE. Route: TRANSDERMAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
Sponsor: GENZYME. Form: INJECTABLE. Route: INJECTION
Sponsor: PF PRISM CV. Form: POWDER. Route: INTRAVENOUS
Sponsor: PF PRISM CV. Form: FOR SUSPENSION. Route: ORAL
Sponsor: NOVARTIS. Form: SUSPENSION. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: FOUGERA PHARMS. Form: OINTMENT. Route: TOPICAL
Sponsor: AM REGENT. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: ORGANON LLC. Form: TABLET. Route: ORAL
Sponsor: APOTEX INC. Form: TABLET. Route: ORAL
Sponsor: APOTEX. Form: TABLET. Route: ORAL
Sponsor: ACTAVIS ELIZABETH. Form: CAPSULE. Route: ORAL
Sponsor: HIKMA. Form: TABLET. Route: ORAL
Sponsor: TEVA. Form: TABLET. Route: ORAL
Sponsor: HERITAGE PHARMA. Form: TABLET. Route: ORAL
Sponsor: HERITAGE PHARMA. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA USA. Form: TABLET. Route: ORAL